Meda settles U.S. Astelin patent litigation with Cobalt

News  |  www.news-medical.net | Aug 25, 2008

Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc. (hereafter Cobalt) that resolves the U.S. patent litigation between the companies regarding Cobalt's proposed generic version of Astelin. Meda, through

http://www.news-medical.net/?id=40870

SinoFresh(R) Nasal Spray Kills MRSA 'Super-Bug' in Live Noses

Press Release  |  www.prnewswire.com | Aug 19, 2008

SinoFresh(R) Passes First Key Test for Potential to Control 'Super-Bug' MRSA VENICE, Fla., Aug. 19 /PRNewswire-FirstCall/ -- SinoFresh HealthCare, Inc.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/08-19-2008/0004870098&EDATE=

China Sky One Medical develops nasal spray for rheumatic disease

News  |  www.pharmaceutical-business-review.com | Aug 18, 2008

China Sky One Medical, a fully integrated pharmaceutical company producing external use, over-the-counter drugs in the Peoples Republic of China, has developed a nasal spray for the treatment and prevention of rheumatic disease.

http://www.pharmaceutical-business-review.com/article_news.asp?guid=C4436520-0122-4AA8-9EB7-5332F448C579

--Schering-Plough's NASONEX Approved in Japan

News  |  www.bioportfolio.co.uk | Jul 18, 2008

Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory

http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=1681445&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=1681445&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz1510719525%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com

NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients (PR Newswire)

News  |  biz.yahoo.com | Jul 17, 2008

NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients. - KENILWORTH, N.J., July 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP - News) today announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing

http://biz.yahoo.com/prnews/080717/nyth057.html?.v=101

Inspire Pharmaceuticals, Inc. to Discontinue Development of Epinastine Nasal Spray

News  |  www.biospace.com | Apr 23, 2008

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH - News) announced today that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR) did not meet its primary endpoint.

http://www.biospace.com/news_story.aspx?StoryID=93613&full=1

AAAAI: Albuterol Said to Work Faster than Combination Agents for Asthma

News  |  www.medpagetoday.com | Mar 20, 2008

PHILADELPHIA -- Inhaled albuterol (Proventil) brought faster increases in asthma patients' lung function than did two corticosteroid-beta agonist combination agents, according to pooled data.</o:

http://www.medpagetoday.com/MeetingCoverage/AAAAIMeeting/tb1/8841

Cayenne Pepper Can Relieve Headaches; This is a Response to the New York Times Article from October 30; Sinol Nasal Spray for Headaches Made with Capsaicin, the Active Ingredient from Cayenne

Press Release  |  www.prweb.com | Oct 31, 2007

PR: Research from various medical facilities and physicians indicate that pepper will indeed relieve headaches. Sinol USA Inc. recently found the manufacturer that has created a solution in a nasal spray that provides faster relief than a pill or a liquid. Sinol USA has created the 1st, all

http://www.prweb.com/releases/2007/10/prweb565452.htm

Paragraph IV Patent Certifications

News  |  www.fda.gov | Oct 2, 2007

Below is a list of drug products for which an Abbreviated New Drug Application (ANDA) has been received by the Office of Generic Drugs (OGD) containing a "Paragraph IV" patent certification.

http://www.fda.gov/cder/ogd/ppiv.htm

MedlinePlus: Steroid nasal spray eases mild sleep apnea in kids

NEW YORK (Reuters Health) - The corticosteroid drug budesonide, given as a nasal spray for 6 weeks, benefits children with mild sleep apnea, a study shows.

http://www.nlm.nih.gov/medlineplus/news/fullstory_66625.html